Initial findings from the Every Woman Study™: Low- and Middle-Income Countries is published in The Lancet Obstetrics, ...
A Hudson Institute research project aiming to better understand and treat rare forms of ovarian cancer has received a big ...
A team of 30 doctors helped Suze Lopez, 41, deliver her son — and remove the tumor — in a "profound" medical marvel.
The doctors explained that they discovered a nearly full-term baby boy developing in a small space in the woman's abdomen ...
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, ...
A GIRL from Studley has taken on a challenge for her auntie who has been diagnosed with terminal cancer, and has had multiple different cancers ...
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...
Thylane Blondeau has revealed the sad news that her stepfather has died. The model, 24, who is the daughter of French ...
The addition of the immune checkpoint inhibitor Tecentriq (atezolizumab) to neoadjuvant chemotherapy and as a single agent ...
Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Dec. 11, 2025 /PRNewswire/ -- Equity Insider News Commentary – November's wave of FDA oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback